Drug Molecule Info Bevacizumab is an anticancer drug mainly indicated in metastatic cancer and to be used in combination with standard chemotherapy in metastatic colon cancer. Recently it has been classified as Specialty Drug for the treatment of rare and complex complications like cancer. This molecular discussion is aimed at indications and precautions of Bevacizumab. Bevacizumab is a recombinant humanized monoclonal antibody that slower the growth of new blood vessels.
It acts by inhibiting vascular endothelial growth factor A (VEGF-E), which stimulates angiogenesis in a variety of diseases, especially in cancer. Initially, it was approved to be used in combination with standard chemotherapy in metastatic colon cancer. However, the approval has been extended for its use in lung cancers, renal cancers, ovarian cancers, and glioblastoma multiforme of the brain. Indications: Metastatic…
